Employer Insights
Navigating the Weight Loss Revolution: The Evolving Role of GLP-1s and Compounded Pharmacies
Recent FDA changes impact GLP-1 compounding, affecting employer benefits and employee access to weight-loss medications. Employers must evaluate coverage strategies and weight-loss platforms for long-term cost and health outcomes.
2025 Drug Pipeline: What It Means for Pharmacy Benefits and the Employee Experience
We’ll break down key trends in the upcoming pipeline and provide actionable insights on how to navigate the changing landscape.
Zepbound's Expanded Use in Obstructive Sleep Apnea
What employers need to know about Zepbound's expanded use in obstructive sleep apnea.
Does a Continuous Glucose Monitor Help Lower Diabetes Costs?
Health professionals who treat patients with diabetes report three advantages of continuous glucose monitoring when compared to a traditional glucose meter.
Three Smart Formulary Management Strategies That Put Your Employees First
Read to learn how employers can strategically manage their formulary strategy to reduce costs and put employees first.
GLP-1s: What You Need to Know Now to Prepare for 2025
Health care spending is projected to rise 8% in 2025, driven by increased use of GLP-1 drugs for diabetes and obesity.
True Rx Health Strategists Launches New Diabetes Management Program for Employers
Patient-centered diabetes program drives significant A1C reduction in just 6 months.
Biosimilars: Are They A Game Changer for Pharmacy Plans?
An Educational Resource from True Rx Health Strategists